Brazil · Delayed Price · Currency is BRL CTI BioPharma Statistics
Total Valuation
BVMF:INTB3 has a market cap or net worth of BRL 4.58 billion. The enterprise value is 4.75 billion.
| Market Cap | 4.58B |
| Enterprise Value | 4.75B |
Important Dates
The last earnings date was Tuesday, July 29, 2025.
| Earnings Date | Jul 29, 2025 |
| Ex-Dividend Date | Aug 4, 2025 |
Share Statistics
BVMF:INTB3 has 327.54 million shares outstanding.
| Current Share Class | 327.54M |
| Shares Outstanding | 327.54M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 64.26% |
| Owned by Institutions (%) | 14.43% |
| Float | 92.30M |
Valuation Ratios
The trailing PE ratio is 10.07 and the forward PE ratio is 7.88. BVMF:INTB3's PEG ratio is 0.60.
| PE Ratio | 10.07 |
| Forward PE | 7.88 |
| PS Ratio | 0.98 |
| PB Ratio | 1.48 |
| P/TBV Ratio | 1.83 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 0.60 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.06, with an EV/FCF ratio of -36.02.
| EV / Earnings | 10.45 |
| EV / Sales | 1.01 |
| EV / EBITDA | 9.06 |
| EV / EBIT | 10.74 |
| EV / FCF | -36.02 |
Financial Position
The company has a current ratio of 2.79, with a Debt / Equity ratio of 0.32.
| Current Ratio | 2.79 |
| Quick Ratio | 1.70 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | 1.88 |
| Debt / FCF | -7.47 |
| Interest Coverage | 5.10 |
Financial Efficiency
Return on equity (ROE) is 15.42% and return on invested capital (ROIC) is 7.09%.
| Return on Equity (ROE) | 15.42% |
| Return on Assets (ROA) | 5.15% |
| Return on Invested Capital (ROIC) | 7.09% |
| Return on Capital Employed (ROCE) | 11.42% |
| Revenue Per Employee | 1.42M |
| Profits Per Employee | 137,854 |
| Employee Count | 3,300 |
| Asset Turnover | 0.88 |
| Inventory Turnover | 2.16 |
Taxes
| Income Tax | -29.82M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -31.01% in the last 52 weeks. The beta is 0.10, so BVMF:INTB3's price volatility has been lower than the market average.
| Beta (5Y) | 0.10 |
| 52-Week Price Change | -31.01% |
| 50-Day Moving Average | 14.90 |
| 200-Day Moving Average | 14.53 |
| Relative Strength Index (RSI) | 40.82 |
| Average Volume (20 Days) | 1,951,270 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BVMF:INTB3 had revenue of BRL 4.70 billion and earned 454.92 million in profits.
| Revenue | 4.70B |
| Gross Profit | 1.37B |
| Operating Income | 442.51M |
| Pretax Income | 424.99M |
| Net Income | 454.92M |
| EBITDA | 517.12M |
| EBIT | 442.51M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 837.64 million in cash and 985.35 million in debt, giving a net cash position of -147.71 million or -0.45 per share.
| Cash & Cash Equivalents | 837.64M |
| Total Debt | 985.35M |
| Net Cash | -147.71M |
| Net Cash Per Share | -0.45 |
| Equity (Book Value) | 3.10B |
| Book Value Per Share | n/a |
| Working Capital | 2.40B |
Cash Flow
In the last 12 months, operating cash flow was -24.95 million and capital expenditures -107.01 million, giving a free cash flow of -131.96 million.
| Operating Cash Flow | -24.95M |
| Capital Expenditures | -107.01M |
| Free Cash Flow | -131.96M |
| FCF Per Share | -0.40 |
Margins
Gross margin is 29.25%, with operating and profit margins of 9.42% and 9.68%.
| Gross Margin | 29.25% |
| Operating Margin | 9.42% |
| Pretax Margin | 9.04% |
| Profit Margin | 9.68% |
| EBITDA Margin | 11.00% |
| EBIT Margin | 9.42% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.46, which amounts to a dividend yield of 3.26%.
| Dividend Per Share | 0.46 |
| Dividend Yield | 3.26% |
| Dividend Growth (YoY) | -19.71% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 50.94% |
| Buyback Yield | n/a |
| Shareholder Yield | 3.26% |
| Earnings Yield | 9.93% |
| FCF Yield | -2.88% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |